Skip to main content
    J

    Jasper Therapeutics Inc (JSPRW)

    Official site

    BIOTECHNOLOGY • NASDAQ

    $0.00
    +0.00 (+0.00%)

    Last updated: Sep 25, 2026 at 5:00 PM ET

    Earnings

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    5 analysts
    Period ending Sep 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $2M
    Range$0 - $12M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-N/A---
    Jun 26EST
    		-N/A---
    Jun 21
    Reported Sep 30
    		$-0.69$0.00N/AMiss+57.2%
    Mar 21
    Reported Jun 30
    		$-0.83$0.00N/AMiss-
    Dec 20
    Reported Mar 31
    		$-0.99$0.00N/AMiss-
    Jun 20
    Reported Sep 30
    		$-6.14$0.00N/AMiss-
    Mar 20
    Reported Jun 30
    		$-1.61$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-255.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta3.04Avg VolumeN/A
    52-Week High$0.1552-Week Low$0.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.00
    SMA 20$0.01
    SMA 50$0.01
    SMA 200$0.03
    EMA 10$0.00
    EMA 20$0.01
    EMA 50$0.01
    EMA 200$0.03

    MACD

    Line: -0.00Signal: -0.00Hist: -0.00

    ADX

    ADX: 85.1+DI: 3.1-DI: 37.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down96.0
    PSAR$0.01

    Bollinger Bands

    Upper Band$0.01
    Lower Band$0.00
    %B Position19729%(Upper)
    Band Width0.01

    RSI (14-Day)

    Oversold
    12.5

    Momentum Oscillators

    Stoch %K1.1
    Stoch %D4.6
    Williams %R-98.9
    ROC (10d)-97.5%
    Momentum-0.01
    CCI (20d)-167.8
    MFI (14d)11.0

    Volatility Measures

    ATR (14d)$0.00(1202.4%)
    StdDev (20d)0.00
    Hist Vol375.3%(High)

    Volume Flow

    VWAP$0.00
    OBV-2.5M
    AD Line-1.0M
    CMF (20d)-0.586

    Volume Metrics

    Avg Vol (20d)102.6K
    Vol RatioN/A
    VWMA (20d)$0.00

    Pivot Points

    R3$0.01
    R2$0.01
    R1$0.00
    Pivot Point$0.00
    S1$-0.00
    S2$-0.00
    S3$-0.00

    Advanced Oscillators

    TSI-61.10
    Ultimate Osc50.5
    KST-604.46

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$1.17M$0$0$0$2.05M$0
    Cost of RevenueN/A$21,000$290,000N/A$258,000$279,000$587,000$541,000$299,000$288,000$82,000$276,000
    Gross ProfitN/A$-21,000$-290,000N/A$-258,000$-279,000$587,000$-541,000$-299,000$-288,000$-82,000$-276,000
    Operating Expenses$9.21M$10.93M$15.84M$19.17M$27.08M$21.80M$25.29M$19.89M$15.99M$14.78M$17.73M$19.36M
    R&D$5.13M$5.81M$11.36M$14.39M$21.20M$16.16M$19.77M$14.46M$11.30M$10.30M$13.84M$14.85M
    SG&A$4.07M$5.12M$4.48M$4.78M$5.88M$5.64M$5.51M$5.43M$4.70M$4.77M$3.89M$4.51M
    Operating Income$-9,207,000$-10,952,000$-15,839,000$-19,166,000$-27,076,000$-21,802,000$-25,285,000$-19,889,000$-15,993,000$-15,072,000$-17,725,000$-19,362,000
    Interest Income$82,000$164,000$338,000$342,000$437,000$624,000$938,000$1.28M$1.45M$1.39M$1.23M$1.43M
    Interest Expense$0$0$0$0$0$0$5.06M$0$0$0$313,000$0
    Income Before Tax$-2,760,000$-1,174,000$-9,101,000$-18,736,000$-26,723,000$-21,241,000$-24,321,000$-18,637,000$-14,583,000$-13,728,000$-16,581,000$-17,544,000
    Income Tax Expense$0$0$0$0$0$0$54,276$0$-299,000$244,724$1.91M$-1,709,000
    Net Income$-2,760,000$-1,174,000$-9,101,000$-18,736,000$-26,723,000$-21,241,000$-24,321,000$-18,637,000$-14,583,000$-13,728,000$-16,581,000$-17,544,000
    EBITDA$-2,739,000$-1,153,000$-8,811,000$-18,507,000$-26,465,000$-20,962,000$-24,076,000$-18,096,000$-14,284,000$-13,440,000$-16,298,000$-17,268,000
    EBIT$-2,760,000$-1,174,000$-9,101,000$-18,736,000$-26,723,000$-21,241,000$-24,321,000$-18,637,000$-14,583,000$-13,728,000$-16,581,000$-17,544,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about JSPRW

    JSPRW Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -255.0%

    JSPRW Competitors

    CompanyTicker
    Protagenic Therapeutics IncPTIXW
    STRATA Skin Sciences IncSSKN
    NeuroSense Therapeutics Ltd. WarrantNRSNW
    P3 Health Partners IncPIIIW
    Genfit S.A.GNFT
    Celularity IncCELUW
    Biofrontera Inc. WarrantsBFRIW
    Metsera, Inc. Common StockMTSR

    Sector: Healthcare

    JSPRW Earnings: Beat Rate and Next Report

    Beat rate
    0 of 5 quarters (0.0%)

    Frequently Asked Questions About JSPRW

    Does JSPRW pay dividends?

    Jasper Therapeutics Inc (JSPRW) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with J

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In